Starmer's US pharma deal criticized as costly threat to NHS and public health

Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law facilitating a US medicine import deal that will cost the NHS billions, diverting funds from doctors, nurses, and cancer care. The piece frames this as a profound democratic fail